SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-361511
Filing Date
2014-10-02
Accepted
2014-10-02 08:01:00
Documents
4
Period of Report
2014-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798511d8k.htm 8-K 18678
2 EX-10.1 d798511dex101.htm EX-10.1 348808
3 EX-99.1 d798511dex991.htm EX-99.1 14496
4 GRAPHIC g798511g61y69.jpg GRAPHIC 4675
  Complete submission text file 0001193125-14-361511.txt   389965
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 141134695
SIC: 2834 Pharmaceutical Preparations